Phase 4 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who are in the late stage of the menopausal transition, as defined by a specific set of reproductive aging guidelines called STRAW+10
- People who score above 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which suggests poor sleep quality
- People who score above 7 on a standard insomnia questionnaire called the Insomnia Severity Index, which suggests moderate to severe insomnia symptoms
- People who score 4 or more points on the physical symptom section of a menopause symptom rating scale called the Menopause Rating Scale II
- People who are willing to use hormone replacement therapy (HRT) to help manage menopause symptoms
Who may not be able to join:
- People who have other sleep or wakefulness disorders as identified by recognised diagnostic guidelines and standard sleep questionnaires
- People who have an untreated hormonal condition
- People with a BMI of 30 or above (classified as obesity)
- People who are currently receiving psychotherapy
- People who are currently taking psychiatric medications or medications regularly used for sleep
- People who have previously tried a specific talking therapy for insomnia (called CBT-I) without success
- People who have a psychiatric illness
- People who smoke 7 or more cigarettes per day, drink more than 2 standard alcoholic drinks per day as defined by the WHO, or use other substances
- People who work shift work
- People who have travelled across multiple time zones on long-haul flights within the past 3 months
- People who are pregnant or breastfeeding
- People for whom hormone replacement therapy is medically unsuitable, as determined by Swiss medication guidelines
- People who are unable to follow the study procedures or do not have sufficient knowledge of the language the study is conducted in
- People who are not able to give informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Petra Stute, Prof., University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
Phone: +41 31 632 1010
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reduction of Insomnia Severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.